BioCentury

7:00 AM GMT, May 5, 2003
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Finance

Restructuring watch

Restructuring watch

Date Company Staff cuts Notes Current Cash Years cash pre-cut 2002 Op loss Cash reporting date
4/28/2003 Aclara (ACLA) 32% to 65 Done to focus on commercializing its eTag assay system; eliminated some executive positions, as well as cuts in

Read the full 427 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.